From: Biochemical predictors of postoperative atrial fibrillation following cardiac surgery
Overall | Patients without POAF | Patients with POAF | p | |
---|---|---|---|---|
Number of patients | 1191 (100) | 861 (72.3) | 330 (27.7) | – |
Demographics | ||||
Age (year), median (min–max) | 63 (16–87) | 61 (16–83) | 69 (29–87) | < 0.001 |
Male gender, n (%) | 691 (58.0%) | 501 (58.1) | 190 (56.8) | 0.94 |
Comorbidities n (%) | ||||
Diabetes | 272 (22.8%) | 177 (20.6) | 95 (28.8) | 0.002 |
Hypertension | 652 (54.7%) | 440 (51.1) | 212 (64.2) | < 0.001 |
Chronic renal failure | 152 (12.8%) | 93 (10.8) | 59 (17.9) | < 0.001 |
COPD | 182 (15.3%) | 113 (13.1) | 69 (20.9) | < 0.001 |
Liver failure | 24 (2.0%) | 10 (1.2) | 14 (4.2) | < 0.001 |
Cerebrovascular disease | 47 (3.9%) | 27 (3.1) | 20 (6.1) | 0.02 |
Peripheral artery disease | 135 (11.3%) | 89 (10.3) | 46 (13.9) | 0.08 |
Previous cardiac surgery | 59 (5.0%) | 31 (3.6) | 28 (8.5) | < 0.001 |
Perioperative factors | ||||
EF (%), median (min–max) | 60 (30–65) | 60 (30–60) | 55 (36–65) | < 0.001 |
Type of operation, n (%) | ||||
Isolated CABG | 599 (50.3%) | 477 (55.4) | 122 (37.0) | < 0.001 |
Isolated valvular intervention | 374 (31.4%) | 241 (28.0) | 133 (40.3) | < 0.001 |
CABG plus valvular intervention | 150 (12.6%) | 82 (9.5) | 68 (20.6) | < 0.001 |
Other | 68 (5.7%) | 61 (7.1) | 7 (2.1) | < 0.001 |
CPB time (min), median (min–max) | 138 (49–319) | 136 (49–319) | 143 (58–270) | < 0.001 |
CC time (min), median (min–max) | 70 (19–245) | 69 (22–245) | 75 (19–165) | < 0.001 |